Ezalife Reports Early Sales Momentum and Institutional Investment Ahead of Crowdfunding Campaign Close
March 28th, 2026 3:00 AM
By: Newsworthy Staff
Medical device company Ezalife has secured $1.6 million from major institutions and reported $19,000 in early sales for its Button Huggie® product, which improves gastrostomy button care, as it nears the end of its equity crowdfunding campaign on StartEngine.

Ezalife, a medical device company focused on improving outcomes for patients with feeding tubes, is gaining early traction as it approaches the final days of its equity crowdfunding campaign on StartEngine, closing April 6. The company recently reported $8,000 in pre-orders followed by $11,000 in its first 30 days of sales, signaling strong early demand for its flagship product, the Button Huggie®. Developed to replace the outdated tape-and-gauze method commonly used to secure gastrostomy buttons (G-buttons), the Button Huggie® is an FDA-registered device that improves stability, comfort, and safety for patients requiring enteral feeding.
Ezalife has also secured $1.6 million in investment from leading institutions, including Children’s Hospital Colorado and the University of Colorado, supporting product development, manufacturing, and supply chain execution. This institutional backing provides significant validation for the company's technology and business strategy. The company's leadership stated that they are seeing validation not only from clinical environments but now from real customers, describing this as a critical step as they scale into broader distribution channels.
The company is now focused on expanding into healthcare provider adoption, insurance reimbursement pathways, and hospital-to-home distribution, positioning itself for continued growth within the global feeding tube market. This strategic focus on multiple distribution channels and reimbursement pathways is essential for scaling medical device adoption and achieving sustainable growth. The early sales figures, combined with substantial institutional investment, suggest market readiness for improved gastrostomy button care solutions.
With its StartEngine campaign nearing close, Ezalife's progress demonstrates how early commercial traction and institutional validation can support growth in the medical device sector. The company's approach addresses a clear clinical need in enteral feeding management, potentially improving quality of life for patients who rely on gastrostomy buttons. The transition from traditional tape-and-gauze methods to specialized devices like the Button Huggie® represents an important advancement in patient care and safety standards.
Source Statement
This news article relied primarily on a press release disributed by NewMediaWire. You can read the source press release here,
